Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

May 1, 2018

Study Completion Date

May 1, 2018

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Nexium

Esomeprazole ( Nexium )40 mg tid daily for 14 days in the high dose dual therapyarm and 40 mg bid daily for 7 days in the non-bismuth quadruple therapy

DRUG

Amolin

Amoxicillin 750 mg qid daily for 14 days in the high dose dual therapy and amoxicillin 1 g bid daily for 7 days in the non-bismuth quadruple therapy

DRUG

Klaricid

clarithromycin 500 mg bid daily for 7 days in the non-bismuth quadruple therapy

DRUG

Flagyl

Metronidazole (Flagyl) 500 mg tid daily for 7 days in the non-bismuth quadruple therapy

Trial Locations (1)

833

Wei-Chen Tai, Kaohsiung City

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT03383003 - Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy | Biotech Hunter | Biotech Hunter